Haloperidol and Zotepine

Shortcuts: Differences, Similarities, Jaccard Similarity Coefficient, References.

Difference between Haloperidol and Zotepine

Haloperidol vs. Zotepine

Haloperidol, marketed under the trade name Haldol among others, is a typical antipsychotic medication. Zotepine (brand names: Losizopilon (JP), Lodopin (ID, JP), Setous (JP), Zoleptil (CZ, PT, TR, UK†); where † indicates a formulation that has been discontinued) is an atypical antipsychotic drug indicated for acute and chronic schizophrenia.

Agranulocytosis

Agranulocytosis, also known as agranulosis or granulopenia, is an acute condition involving a severe and dangerous leukopenia (lowered white blood cell count), most commonly of neutrophils causing a neutropenia in the circulating blood.

Agranulocytosis and Haloperidol · Agranulocytosis and Zotepine · See more »

Alpha-1A adrenergic receptor

The alpha-1A adrenergic receptor (α1A adrenoreceptor), also known as ADRA1A, formerly known also as the alpha-1C adrenergic receptor, is an alpha-1 adrenergic receptor, and also denotes the human gene encoding it.

Alpha-1A adrenergic receptor and Haloperidol · Alpha-1A adrenergic receptor and Zotepine · See more »

Alpha-2A adrenergic receptor

The alpha-2A adrenergic receptor (α2A adrenoceptor), also known as ADRA2A, is an α2 adrenergic receptor, and also denotes the human gene encoding it.

Alpha-2A adrenergic receptor and Haloperidol · Alpha-2A adrenergic receptor and Zotepine · See more »

Alpha-2B adrenergic receptor

The alpha-2B adrenergic receptor (α2B adrenoceptor), is a G-protein coupled receptor.

Alpha-2B adrenergic receptor and Haloperidol · Alpha-2B adrenergic receptor and Zotepine · See more »

Alpha-2C adrenergic receptor

The alpha-2C adrenergic receptor (α2C adrenoceptor), also known as ADRA2C, is an alpha-2 adrenergic receptor, and also denotes the human gene encoding it.

Alpha-2C adrenergic receptor and Haloperidol · Alpha-2C adrenergic receptor and Zotepine · See more »

Anemia

Anemia is a decrease in the total amount of red blood cells (RBCs) or hemoglobin in the blood, or a lowered ability of the blood to carry oxygen.

Anemia and Haloperidol · Anemia and Zotepine · See more »

Aripiprazole

Aripiprazole, sold under the brand name Abilify among others, is an atypical antipsychotic. It is recommended and primarily used in the treatment of schizophrenia and bipolar disorder. Other uses include as an add-on treatment in major depressive disorder, tic disorders, and irritability associated with autism. According to a Cochrane review, evidence for the oral form in schizophrenia is not sufficient to determine effects on general functioning. Additionally, because many people dropped out of the medication trials before they were completed, the overall strength of the conclusions is low. Side effects include neuroleptic malignant syndrome, a movement disorder known as tardive dyskinesia, and high blood sugar in those with diabetes. In the elderly there is an increased risk of death. It is thus not recommended for use in those with psychosis due to dementia. It is pregnancy category C in the United States and category C in Australia, meaning there is possible evidence of harm to the fetus. It is not recommended for women who are breastfeeding. It is unclear whether it is safe or effective in people less than 18 years old. It is a partial dopamine agonist. Aripiprazole was developed by Otsuka in Japan. In the United States, Otsuka America markets it jointly with Bristol-Myers Squibb. From April 2013 to March 2014, sales of Abilify amounted to almost $6.9 billion.

Aripiprazole and Haloperidol · Aripiprazole and Zotepine · See more »

Cholestasis

Cholestasis is a condition where bile cannot flow from the liver to the duodenum.

Cholestasis and Haloperidol · Cholestasis and Zotepine · See more »

Dopamine receptor D1

Dopamine receptor D1, also known as DRD1, is a protein that in humans is encoded by the DRD1 gene.

Dopamine receptor D1 and Haloperidol · Dopamine receptor D1 and Zotepine · See more »

Dopamine receptor D2

Dopamine receptor D2, also known as D2R, is a protein that, in humans, is encoded by the DRD2 gene.

Dopamine receptor D2 and Haloperidol · Dopamine receptor D2 and Zotepine · See more »

Dopamine receptor D3

Dopamine receptor D3 is a protein that in humans is encoded by the DRD3 gene.

Dopamine receptor D3 and Haloperidol · Dopamine receptor D3 and Zotepine · See more »

Dopamine receptor D4

The dopamine receptor D4 is a dopamine D2-like G protein-coupled receptor encoded by the gene on chromosome 11 at 11p15.5.

Dopamine receptor D4 and Haloperidol · Dopamine receptor D4 and Zotepine · See more »

Dopamine receptor D5

Dopamine receptor D5, also known as D1BR, is a protein that in humans is encoded by the DRD5 gene.

Dopamine receptor D5 and Haloperidol · Dopamine receptor D5 and Zotepine · See more »

Extrapyramidal symptoms

Extrapyramidal symptoms (EPS), also known as extrapyramidal side effects (EPSE), are drug-induced movement disorders that include acute and tardive symptoms.

Extrapyramidal symptoms and Haloperidol · Extrapyramidal symptoms and Zotepine · See more »

Histamine H1 receptor

The H1 receptor is a histamine receptor belonging to the family of rhodopsin-like G-protein-coupled receptors.

Haloperidol and Histamine H1 receptor · Histamine H1 receptor and Zotepine · See more »

Hypotension

Hypotension is low blood pressure, especially in the arteries of the systemic circulation.

Haloperidol and Hypotension · Hypotension and Zotepine · See more »

Ileus

Ileus is a disruption of the normal propulsive ability of the gastrointestinal tract.

Haloperidol and Ileus · Ileus and Zotepine · See more »

Leukopenia

Leukopenia is a decrease in the number of white blood cells (leukocytes) found in the blood, which places individuals at increased risk of infection.

Haloperidol and Leukopenia · Leukopenia and Zotepine · See more »

Ligand (biochemistry)

In biochemistry and pharmacology, a ligand is a substance that forms a complex with a biomolecule to serve a biological purpose.

Haloperidol and Ligand (biochemistry) · Ligand (biochemistry) and Zotepine · See more »

Muscarinic acetylcholine receptor M1

The muscarinic acetylcholine receptor M1, also known as the cholinergic receptor, muscarinic 1, is a muscarinic receptor that in humans is encoded by the CHRM1 gene.

Haloperidol and Muscarinic acetylcholine receptor M1 · Muscarinic acetylcholine receptor M1 and Zotepine · See more »

Neuroleptic malignant syndrome

Neuroleptic malignant syndrome (NMS) is a life-threatening reaction that occasionally occurs in response to neuroleptic or antipsychotic medication.

Haloperidol and Neuroleptic malignant syndrome · Neuroleptic malignant syndrome and Zotepine · See more »

Neutropenia

Neutropenia or neutropaenia is an abnormally low concentration of neutrophils (a type of white blood cell) in the blood.

Haloperidol and Neutropenia · Neutropenia and Zotepine · See more »

Orthostatic hypotension

Orthostatic hypotension, also known as postural hypotension, occurs when a person's blood pressure falls when suddenly standing up from a lying or sitting position.

Haloperidol and Orthostatic hypotension · Orthostatic hypotension and Zotepine · See more »

Paliperidone

Paliperidone, sold under the trade name Invega among others, is a dopamine antagonist and 5-HT2A antagonist of the atypical antipsychotic class of medications.

Haloperidol and Paliperidone · Paliperidone and Zotepine · See more »

Pharmacodynamics

Pharmacodynamics is the study of the biochemical and physiologic effects of drugs (especially pharmaceutical drugs).

Haloperidol and Pharmacodynamics · Pharmacodynamics and Zotepine · See more »

QT interval

In cardiology, the QT interval is a measure of the time between the start of the Q wave and the end of the T wave in the heart's electrical cycle.

Haloperidol and QT interval · QT interval and Zotepine · See more »

Quetiapine

Quetiapine, marketed as Seroquel among other names, is an atypical antipsychotic used for the treatment of schizophrenia, bipolar disorder, and major depressive disorder.

Haloperidol and Quetiapine · Quetiapine and Zotepine · See more »

Schizophrenia

Schizophrenia is a mental disorder characterized by abnormal social behavior and failure to understand reality.

Haloperidol and Schizophrenia · Schizophrenia and Zotepine · See more »

Shortness of breath

Shortness of breath, also known as dyspnea, is the feeling that one cannot breathe well enough.

Haloperidol and Shortness of breath · Shortness of breath and Zotepine · See more »

Somnolence

Somnolence (alternatively "sleepiness" or "drowsiness") is a state of strong desire for sleep, or sleeping for unusually long periods (compare hypersomnia).

Haloperidol and Somnolence · Somnolence and Zotepine · See more »

Tardive dyskinesia

Tardive dyskinesia (TD) is a disorder that results in involuntary, repetitive body movements.

Haloperidol and Tardive dyskinesia · Tardive dyskinesia and Zotepine · See more »

Thrombocytopenia

Thrombocytopenia is a condition characterized by abnormally low levels of thrombocytes, also known as platelets, in the blood.

Haloperidol and Thrombocytopenia · Thrombocytopenia and Zotepine · See more »

5-HT1A receptor

The serotonin 1A receptor (or 5-HT1A receptor) is a subtype of serotonin receptor (5-HT receptor) that binds the neurotransmitter serotonin (5-hydroxytryptamine, 5-HT).

5-HT1A receptor and Haloperidol · 5-HT1A receptor and Zotepine · See more »

5-HT2A receptor

The mammalian 5-HT2A receptor is a subtype of the 5-HT2 receptor that belongs to the serotonin receptor family and is a G protein-coupled receptor (GPCR).

5-HT2A receptor and Haloperidol · 5-HT2A receptor and Zotepine · See more »

5-HT2C receptor

The 5-HT2C receptor is a subtype of 5-HT receptor that binds the endogenous neurotransmitter serotonin (5-hydroxytryptamine, 5-HT).

5-HT2C receptor and Haloperidol · 5-HT2C receptor and Zotepine · See more »

5-HT6 receptor

The 5HT6 receptor is a subtype of 5HT receptor that binds the endogenous neurotransmitter serotonin (5-hydroxytryptamine, 5HT).

5-HT6 receptor and Haloperidol · 5-HT6 receptor and Zotepine · See more »

5-HT7 receptor

The 5-HT7 receptor is a member of the GPCR superfamily of cell surface receptors and is activated by the neurotransmitter serotonin (5-hydroxytryptamine, 5-HT) The 5-HT7 receptor is coupled to Gs (stimulates the production of the intracellular signaling molecule cAMP) and is expressed in a variety of human tissues, particularly in the brain, the gastrointestinal tract, and in various blood vessels.

5-HT7 receptor and Haloperidol · 5-HT7 receptor and Zotepine · See more »